These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1722790)

  • 41. Etiology of benign prostatic hyperplasia.
    Isaacs JT
    Eur Urol; 1994; 25 Suppl 1():6-9. PubMed ID: 7507055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.
    Partin AW; Oesterling JE; Epstein JI; Horton R; Walsh PC
    J Urol; 1991 Feb; 145(2):405-9. PubMed ID: 1703242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays.
    Prakash K; Pirozzi G; Elashoff M; Munger W; Waga I; Dhir R; Kakehi Y; Getzenberg RH
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7598-603. PubMed ID: 12032329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Origin and structure of benign prostatic hyperplasia.
    Jones DR; Parkinson MC; Griffiths GJ; Davies RL; Peeling WB
    Br J Urol; 1990 Nov; 66(5):506-8. PubMed ID: 1701106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Histologic components of benign prostatic hypertrophy (bph) in relation to the androgen-estrogen status (author's transl)].
    Seppelt U; Buhl K; Drews M
    Urologe A; 1978 Mar; 17(2):117-9. PubMed ID: 76360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benign prostatic hyperplasia. The scope of the problem.
    Grayhack JT
    Cancer; 1992 Jul; 70(1 Suppl):275-9. PubMed ID: 1376196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between liver cirrhosis and benign prostatic hyperplasia: a morphological study.
    Frea B; Annoscia S; Stanta G; Lozzi C; Carmignani G
    Urol Res; 1987; 15(5):311-4. PubMed ID: 2446412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On call. As a retired physician, I particularly appreciate "Harvard Men's Health Watch" since it's an easy way for me to learn about new developments in medicine. As a 78-year-old man with an enlarged prostate, I'm particularly interested in your fine articles about BPH. But if memory serves me right, we called the condition "benign prostatic hypertrophy" when I was in practice, but now you call it "benign prostatic hyperplasia." What's the difference?
    Simon HB
    Harv Mens Health Watch; 2012 May; 16(10):8. PubMed ID: 22670285
    [No Abstract]   [Full Text] [Related]  

  • 49. Endocrine treatment of benign prostatic hypertrophy: current concepts.
    Matzkin H; Braf Z
    Urology; 1991 Jan; 37(1):1-16. PubMed ID: 1702565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathophysiology of benign prostatic hyperplasia.
    Algaba F
    Eur Urol; 1994; 25 Suppl 1():3-5. PubMed ID: 7507054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lifetime occupational and recreational physical activity and risk of benign prostatic hyperplasia.
    Dal Maso L; Zucchetto A; Tavani A; Montella M; Ramazzotti V; Polesel J; Bravi F; Talamini R; La Vecchia C; Franceschi S
    Int J Cancer; 2006 May; 118(10):2632-5. PubMed ID: 16380994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pathogenesis of benign prostatic hyperplasia: a proposed hypothesis and critical evaluation.
    Grayhack JT; Kozlowski JM; Lee C
    J Urol; 1998 Dec; 160(6 Pt 2):2375-80. PubMed ID: 9817388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenesis of benign prostatic hyperplasia.
    Bosch RJ
    Eur Urol; 1991; 20 Suppl 1():27-30. PubMed ID: 1722157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The etiology of benign prostatic hypertrophy.
    Roper WG
    Med Hypotheses; 1998 Jan; 50(1):61-5. PubMed ID: 9488184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed.
    Boyle P; McGinn R; Maisonneuve P; La Vecchia C
    Eur Urol; 1991; 20 Suppl 1():3-10. PubMed ID: 1722158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The natural history and course of untreated benign prostatic hyperplasia.
    Uson AC; Paez AB; Uson-Jaeger J
    Eur Urol; 1991; 20 Suppl 1():22-6. PubMed ID: 1722156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chronic congestion as genesis of the prostatic adenoma, secondary hormonal changes].
    Hak-Hagir A
    Z Urol Nephrol; 1976 Apr; 69(4):275-8. PubMed ID: 60015
    [No Abstract]   [Full Text] [Related]  

  • 58. Mesenchymal stem cells and the embryonic reawakening theory of BPH.
    Brennen WN; Isaacs JT
    Nat Rev Urol; 2018 Nov; 15(11):703-715. PubMed ID: 30214054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrinsic and extrinsic factors controlling benign prostatic growth.
    Lee C; Kozlowski JM; Grayhack JT
    Prostate; 1997 May; 31(2):131-8. PubMed ID: 9140127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Benign prostate hyperplasia as an age-related problem].
    Vovk EI; Vertkin AL; Zaĭrat'iants OV; Mishutchenko OP
    Arkh Patol; 2008; 70(2):55-9. PubMed ID: 18540448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.